Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
DMK Pharmaceuticals
AddedFeb 19, 2024
UpdatedJun 18, 2026
DMK Pharmaceuticals

DMK Pharmaceuticals

DMK Pharmaceuticals: Pioneering non-addictive treatments for opioid use and central nervous disorders.

HQ
Gladstone, NJ, US
Overview
Compare
Fundraising
Employees

DMK Pharmaceuticals is dedicated to pioneering non-addictive treatments for opioid use disorder and central nervous system disorders. The company focuses on helping patients manage conditions such as chronic pain, Parkinson's disease, depression, and bladder problems, aiming to improve quality of life without the risk of addiction.

DMK Pharmaceuticals has made significant strides in developing innovative therapies that address these critical health issues. Their impact is evident in the enhanced lives of patients who benefit from their non-addictive treatment options.

DMK Pharmaceuticals - Similar Companies

Adamis Pharmaceuticals ada logo

Adamis Pharmaceuticals ada

DemeRx logo

DemeRx

demerx.com

PleoPharma logo

PleoPharma

pleopharma.com

D&D Pharmatech logo

D&D Pharmatech

Phoenix PharmaLabs logo

Phoenix PharmaLabs

Tremeau Pharmaceuticals logo

Tremeau Pharmaceuticals

Kadmus Pharmaceuticals logo

Kadmus Pharmaceuticals

Defender Pharmaceuticals logo

Defender Pharmaceuticals

defenderpharma.com

Assertio Holdings logo

Assertio Holdings

Quartet Medicine logo

Quartet Medicine

Melt Pharmaceuticals logo

Melt Pharmaceuticals

Vanda Pharmaceuticals logo

Vanda Pharmaceuticals

Elite Pharmaceuticals logo

Elite Pharmaceuticals

elitepharma.com

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

CSR Pharma Group logo

CSR Pharma Group

csrpharmsvcs.com

DMK Pharmaceuticals - Quick Facts

Who are DMK Pharmaceuticals' competitors?

Companies similar to DMK Pharmaceuticals include Adamis Pharmaceuticals ada, DemeRx, PleoPharma and D&D Pharmatech.

Where is DMK Pharmaceuticals' headquarters located?

DMK Pharmaceuticals' headquarters is located in Gladstone, NJ, US.

How much has DMK Pharmaceuticals raised to-date?

As of Jun 26, 2023, DMK Pharmaceuticals has raised a total of $150k (USD).

How many employees does DMK Pharmaceuticals have?

DMK Pharmaceuticals has 2 employees as of Feb 5, 2024.

DMK Pharmaceuticals - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research